» Authors » Keith J Roberts

Keith J Roberts

Explore the profile of Keith J Roberts including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 155
Citations 1440
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Varghese T, Andrews C, Fisher L, Goldacre B, Mehrkar A, Pande R, et al.
Semin Oncol Nurs . 2024 Jul; 40(5):151688. PMID: 39043534
Objectives: In the UK, guidelines recommend pancreatic enzyme replacement therapy (PERT) to all people with unresectable pancreatic cancer. In 2023, we published a national audit of PERT which showed suboptimal...
12.
Stoop T, Oba A, Wu Y, Beaty L, Colborn K, Janssen B, et al.
JAMA Netw Open . 2024 Jun; 7(6):e2417625. PMID: 38888920
Importance: Preoperative chemo(radio)therapy is increasingly used in patients with localized pancreatic adenocarcinoma, leading to pathological complete response (pCR) in a small subset of patients. However, multicenter studies with in-depth data...
13.
Uijterwijk B, Lemmers D, Ghidini M, Wilmink H, Zaniboni A, Salvia R, et al.
Ann Surg Oncol . 2024 Jun; 31(9):6157-6169. PMID: 38888860
Background: Cancer arising in the periampullary region can be anatomically classified in pancreatic ductal adenocarcinoma (PDAC), distal cholangiocarcinoma (dCCA), duodenal adenocarcinoma (DAC), and ampullary carcinoma. Based on histopathology, ampullary carcinoma...
14.
Merali N, Chouari T, Sweeney C, Halle-Smith J, Jessel M, Wang B, et al.
Int J Surg . 2024 Jun; 110(10):6771-6799. PMID: 38874485
Background: Pancreatic cancer, specifically pancreatic ductal adenocarcinoma (PDAC), continues to pose a significant clinical and scientific challenge. The most significant finding of recent years is that PDAC tumours harbour their...
15.
Uijterwijk B, Lemmers D, Ghidini M, Wilmink J, Zaniboni A, Fusai G, et al.
Br J Cancer . 2024 May; 131(1):117-125. PMID: 38806725
Background: Despite differences in tumour behaviour and characteristics between duodenal adenocarcinoma (DAC), the intestinal (AmpIT) and pancreatobiliary (AmpPB) subtype of ampullary adenocarcinoma and distal cholangiocarcinoma (dCCA), the effect of adjuvant...
16.
Rajagopalan A, Aroori S, Russell T, Labib P, Ausania F, Pando E, et al.
HPB (Oxford) . 2024 May; 26(8):981-989. PMID: 38755085
Background: Diabetes mellitus (DM) has a complex relationship with pancreatic cancer. This study examines the impact of preoperative DM, both recent-onset and pre-existing, on long-term outcomes following pancreatoduodenectomy (PD) for...
17.
Labib P, Russell T, Denson J, Puckett M, Ausania F, Pando E, et al.
Eur J Surg Oncol . 2024 May; 50(6):108353. PMID: 38701690
Introduction: Patients undergoing pancreaticoduodenectomy for distal cholangiocarcinoma (dCCA) often develop cancer recurrence. Establishing timing, patterns and risk factors for recurrence may help inform surveillance protocol strategies or select patients who...
18.
Uijterwijk B, Lemmers D, Fusai G, Zerbi A, Salvia R, Sparrelid E, et al.
Ann Surg Oncol . 2024 Apr; 31(7):4654-4664. PMID: 38602578
Background: Standard lymphadenectomy for pancreatoduodenectomy is defined for pancreatic ductal adenocarcinoma and adopted for patients with non-pancreatic periampullary cancer (NPPC), ampullary adenocarcinoma (AAC), distal cholangiocarcinoma (dCCA), or duodenal adenocarcinoma (DAC)....
19.
Joshi K, M Espino D, Shepherd D, Mahmoodi N, Roberts K, Chatzizacharias N, et al.
Pancreatology . 2024 Apr; 24(4):624-629. PMID: 38580492
Postoperative pancreatic fistula (POPF) is a major cause of morbidity and mortality after pancreatoduodenectomy (PD), and previous research has focused on patient-related risk factors and comparisons between anastomotic techniques. However,...
20.
Halle-Smith J, Pathak S, Frampton A, Pandanaboyana S, Sutcliffe R, Davidson B, et al.
BJS Open . 2024 Mar; 8(2). PMID: 38513279
No abstract available.